Segra International has executed a nursery provision agreement with Galaxiavertical, a Portugal-based cannabis nursery focused on the high-end supply of cannabis cuttings.
Under this agreement, Segra will support Galaxia with a recurring supply of cannabis cultivars in the form of clean stock, tissue culture plantlets to be used for clonal propagation of 1st generation cuttings.
Galaxia will supply high potency cannabis genetics to the medicinal cannabis industry. With this agreement, Galaxia will now have access to a selection of cultivars from Segra's vast genetic portfolio to distribute to cultivators within Portugal. Ongoing refreshments of these cultivars, and other available cultivars from Segra, will be provided to Galaxia as direct from tissue culture plantlets to be used as mother stock plants.
"As the Portuguese cannabis market continues to grow, cultivators within the region have struggled with finding quality starting genetics for their large-scale operations," said Jamie Blundell, Segra's Chief Executive Officer. "Many cultivators in Portugal have imported cannabis genetics in the form of seed, which results in non-uniform production crops and it takes a significant amount of time to select desirable phenotypes that would later be used for clonal propagation. Through this distribution partnership, Segra will be enabling Galaxia to essentially skip the time-consuming process of phenotype selection from seed and begin propagation from clonal tissue culture plants of proven cultivars right away.”
Galaxia’s Head of Production, Dr. Chris Murray said “The distribution partnership agreement recently signed with Segra is an exciting milestone for Galaxia. The agreement enables Galaxia to access clean tissue culture plantlets from Segra’s genetic portfolio of 1st generation cuttings at our facility in Benavente, Portugal. Our capability to supply to licensed cultivators a range of 1st generation cuttings, adapted to the Portuguese environment, whilst providing assurance that cuttings are free of pests, viruses and have a high level of disease resistance, will significantly de-risk licensed cultivators’ operations.”
For more information:
Segra International Corp.
#108 – 21300 Gordon Way
Richmond, BC, Canada
segra-intl.com